- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A PCT complained a sponsored ‘Primary Care Report’ looked like disguised promotion for Clenil Modulite and misquoted DoH policy. The PMCPA Panel…
Anonymous GP alleged free-loan I-neb nebulisers with Promixin were an inducement and that reps made unproven dose-equivalence claims. Panel found the package…
Allergan press-release content placed in trade journals implied Bocouture/Xeomin was less potent than Vistabel/Botox. PMCPA ruled breach of undertaking (Clause 25) and…
Anonymous GP complaint about a product standardization programme in Northern Ireland. Case did not go before the Panel; programme already withdrawn. No…
A complaint about a Novartis tweet relating to liver disease. The PMCPA concluded no breach because the matter was outwith the scope…
Complaint alleged Lilly bypassed hospital pharmacy governance in a compassionate supply of Olumiant and risked patient safety. Panel found supply ultimately went…
PMCPA case AUTH/2899/11/16 (Director v Aegerion) concerning clinical trial disclosure for Lojuxta. Outcome: No breach and outwith the scope of the Code.
A POM ad for Ilube on a journal bellyband was visible through a transparent postal wrapper. PMCPA ruled this amounted to promotion…
Two Camurus UK representatives attended a Champions League match with a UK health professional during an international congress and provided drinks afterwards.…
Anonymous ex-employee alleged an online trade-journal interview promoted unlicensed medicines to the public. Panel found PME targeted pharma executives and Indivior didn’t…
Pharmasure’s Meriofert detail aid implied superiority vs Menopur using non-inferiority studies, secondary endpoints and selective safety tables. Multiple breaches were found; one…
Complaint alleged a third-party therapy review provider linked client “product/therapy priorities” to reviews. Panel and Appeal Board had concerns about the email’s…
PMCPA found Janssen’s Janssen Response landing page breached the Code because PI links took two clicks (not single-click) and a disclaimer wrongly…
PfizerPro ‘hidden’ Useful Resources page for Sayana-Press appeared in Google results without prescribing info. Panel found it wasn’t intended for HCPs and…
Sanofi’s Dupixent website hosted a NICE guidance resource with Oct 2017 prescribing information and an HCP guide stating asthma safety/efficacy not established.…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.